A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...

Cystic fibrosis, a genetic disease that attacks the lungs, affects roughly 1 in 3,000 people, and cystic fibrosis-related diabetes (CFRD) is its most common complication, a rare and unique type ...

In December, the FDA approved Vertex’s vanzacaftor, tezacaftor and deutivacaftor (Alyftrek) for the treatment of cystic fibrosis in patients with at least one F508del mutation or another ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

Davis left with an abdominal muscle strain with 2:10 remaining in the first quarter and the Lakers holding a 20-17 lead in Philadelphia. Afterward, the 76ers, playing without Joel Embiid and Paul ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

January 29 - The Los Angeles Lakers will be without star big man Anthony Davis for at least a week due to an abdominal strain. The injury occurred during the first quarter of Tuesday's 118-104 ...

Adults with cystic fibrosis experience higher pain prevalence and severity compared to healthy controls, with significant unmet needs in pain management. New study highlights critical gaps in care.

Already sidelined with a torn UCL in his left hand, the sophomore wing also is dealing with a small abdominal tear, coach Rick Pitino said Friday before St. Johns big battle against Villanova on ...